Namrata (Neena) Vijayvergia, MD is a nationally recognized gastrointestinal medical oncologist and a leading advocate for patients living with neuroendocrine cancer. As Section Chief of Gastrointestinal Oncology at Fox Chase Cancer Center, she brings serious expertise and a strong commitment to improving outcomes for individuals with both well‑differentiated and high‑grade neuroendocrine tumors. Sixty percent of her clinical practice is devoted specifically to NET patients, supported by nearly a decade of focused experience and multiple NET‑related research publications.
Dr. Vijayvergia is an active and influential voice within the neuroendocrine community. She contributes to national and international guideline panels—including NANETS, ENETS, NCCN, and ASCO—where she helps shape standards of care for complex NET presentations, including high‑grade and grade 3 disease. Her research spans novel therapeutic targets, immunotherapy, PRRT, and biomarker‑driven approaches, all aimed at advancing effective, personalized treatment strategies for NET patients.
A frequent invited speaker at major global conferences, Dr. Vijayvergia is recognized not only for her scientific leadership but for her commitment to patient‑centered, compassionate care—values that align closely with NCAN’s mission to support, educate, and empower the NET community.